Clinical Trials Logo

Clinical Trial Summary

Retinal vessel occlusions might lead to ischemia of the inner retina, more severe so in artery occlusions. Intracellular edema may develop and decrease transparency of those layers, showing retinal edema. In spectral domain optical coherence tomography (SD-OCT) retinal reflectivity changes as a result of retinal edema. The investigators examine the reflectivity changes of different retinal layers between healthy eyes and eyes with retinal artery occlusion and ischemic or non-ischemic vein occlusions. Aim of the study is to evaluate whether those changes can be used to measure the level of ischemia in the inner retina.


Clinical Trial Description

Several studies tried to classify retinal ischemia due to retinal artery or vein occlusion into different grades. In some cases prognosis is dependent on grade of severity, especially in cases of retinal vein occlusion. State of the art to Diagnose the severity of retinal ischemia is lfuorescein angiography. However, this technique is invasive and might cause Problems like anaphylactic shock. Optical coherence tomography is a non-invasive technique, but up to now there is no standardized method to quantify the grade of severity of retinal ischemia in such conditions like retinal vessel occlusion. The study hope to find criteria by which such a classification can be constructed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03061526
Study type Observational
Source Technische Universität Dresden
Contact Egbert Matthé, MD
Phone +493514583381
Email egbert.matthe@uniklinikum-dresden.de
Status Recruiting
Phase
Start date May 1, 2017
Completion date December 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT03730779 - Oxygen Therapy for Retinal Ischemia Phase 4
Completed NCT03906383 - Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes N/A
Active, not recruiting NCT03422965 - Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus N/A
Completed NCT00841373 - Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease Phase 1/Phase 2
Recruiting NCT04038125 - Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME Phase 4